offline
Danaher (DHR) Q3 Earnings Beat, Rise Y/Y on Sales Growth
...
The company’s adjusted earnings were $1.72 per share in the reported quarter, which outpaced the Zacks Consensus Estimate of $1.37. The bottom line increased 62.3% from the year-ago quarter’s figure of $1.06 mainly on sales growth and improved operating margin.
Revenue Details
In the quarter under review, the company’s net sales were $5,883.2 million, reflecting year-over-year growth of 34.5%. The results were driven by solid performance in Life Sciences and Diagnostics segments.
...
https://finance.yahoo.com/news/danaher-d...02147.html
![[Bild: DHRc1dl1626.png]](https://finviz.com/publish/102320/DHRc1dl1626.png)
...
The company’s adjusted earnings were $1.72 per share in the reported quarter, which outpaced the Zacks Consensus Estimate of $1.37. The bottom line increased 62.3% from the year-ago quarter’s figure of $1.06 mainly on sales growth and improved operating margin.
Revenue Details
In the quarter under review, the company’s net sales were $5,883.2 million, reflecting year-over-year growth of 34.5%. The results were driven by solid performance in Life Sciences and Diagnostics segments.
...
https://finance.yahoo.com/news/danaher-d...02147.html
__________________
